Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 1
2022 2
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Meyer Sauteur PM, Chalker VJ, Berger C, Nir-Paz R, Beeton ML; ESGMAC and the ESGMAC–MyCOVID study group. Meyer Sauteur PM, et al. Lancet Microbe. 2022 Dec;3(12):e897. doi: 10.1016/S2666-5247(22)00190-2. Epub 2022 Aug 11. Lancet Microbe. 2022. PMID: 35964636 Free PMC article. No abstract available.
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.
Welzel T, Atkinson A, Schöbi N, Andre MC, Bailey DGN, Blanchard-Rohner G, Buettcher M, Grazioli S, Koehler H, Perez MH, Trück J, Vanoni F, Zimmermann P, Sanchez C, Bielicki JA, Schlapbach LJ; Swissped RECOVERY Trial Group. Welzel T, et al. Lancet Child Adolesc Health. 2023 Apr;7(4):238-248. doi: 10.1016/S2352-4642(23)00020-2. Epub 2023 Feb 3. Lancet Child Adolesc Health. 2023. PMID: 36746174 Free PMC article.
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial.
Andre MC, Sanchez C, Bressieux-Degueldre S, Perez MH, Wütz D, Blanchard-Rohner G, Grazioli S, Schöbi N, Trück J, Welzel T, Atkinson A, Schlapbach LJ, Bielicki J; Swissped RECOVERY Trial Group. Andre MC, et al. EClinicalMedicine. 2023 Dec 6;67:102358. doi: 10.1016/j.eclinm.2023.102358. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38107550 Free PMC article.
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.
Blanchard-Rohner G, Sanchez C, Andre MC, Bressieux-Degueldre S, Grazioli S, Perez MH, Wütz D, Schöbi N, Welzel T, Atkinson A, Schlapbach LJ, Bielicki JA, Trück J; Swissped RECOVERY Trial Group. Blanchard-Rohner G, et al. Pediatr Infect Dis J. 2024 Apr 1;43(4):361-364. doi: 10.1097/INF.0000000000004206. Epub 2024 Jan 15. Pediatr Infect Dis J. 2024. PMID: 38241661 Free PMC article.
Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study.
Kuemmerle A, Sikalengo G, Vanobberghen F, Ndege RC, Foe G, Schlaeppi C, Burri C, Battegay M, Paris DH, Glass TR, Weisser M, Marzolini C; KIULARCO Study Group. Kuemmerle A, et al. Among authors: schlaeppi c. J Antimicrob Chemother. 2021 Sep 15;76(10):2681-2689. doi: 10.1093/jac/dkab254. J Antimicrob Chemother. 2021. PMID: 34337653
Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
Schlaeppi C, Vanobberghen F, Sikalengo G, Glass TR, Ndege RC, Foe G, Kuemmerle A, Paris DH, Battegay M, Marzolini C, Weisser M; Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) study group. Schlaeppi C, et al. HIV Med. 2020 Jan;21(1):53-63. doi: 10.1111/hiv.12801. Epub 2019 Sep 18. HIV Med. 2020. PMID: 31532898 Free PMC article.